tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

FDMT Stock Latest News

Optimistic Buy Rating for 4D-150 Driven by PRISM Study’s Promising Results in Treating Wet Age-Related Macular Degeneration
RatingsOptimistic Buy Rating for 4D-150 Driven by PRISM Study’s Promising Results in Treating Wet Age-Related Macular Degeneration
12d ago
FDMT
4D Molecular price target lowered to $30 from $39 at Chardan
PremiumThe Fly
4D Molecular price target lowered to $30 from $39 at Chardan
12d ago
FDMT
4D Molecular’s wAMD drug is best-in-class, says RBC, sees ‘ideal’ entry point
PremiumThe Fly
4D Molecular’s wAMD drug is best-in-class, says RBC, sees ‘ideal’ entry point
12d ago
ADVM
FDMT
Cautious ‘Hold’ Rating on 4D Molecular Therapeutics Amidst Competitive Market and Investor Concerns
PremiumRatings
Cautious ‘Hold’ Rating on 4D Molecular Therapeutics Amidst Competitive Market and Investor Concerns
12d ago
FDMT
4D Molecular Therapeutics: Strong Buy Rating on Promising 4D-150 Gene Therapy Data and Strategic Phase 3 Trials
PremiumRatings
4D Molecular Therapeutics: Strong Buy Rating on Promising 4D-150 Gene Therapy Data and Strategic Phase 3 Trials
12d ago
FDMT
Promising Prospects for 4D Molecular Therapeutics: Anticipated Growth in wAMD Treatment and Market Valuation
PremiumRatingsPromising Prospects for 4D Molecular Therapeutics: Anticipated Growth in wAMD Treatment and Market Valuation
16d ago
FDMT
4D Molecular price target lowered to $42 from $46 at BofA
Premium
The Fly
4D Molecular price target lowered to $42 from $46 at BofA
1M ago
FDMT
4D Molecular price target lowered to $6 from $8 at Morgan Stanley
Premium
The Fly
4D Molecular price target lowered to $6 from $8 at Morgan Stanley
1M ago
FDMT
4D Molecular downgraded to Market Perform from Outperform at BMO Capital
PremiumThe Fly
4D Molecular downgraded to Market Perform from Outperform at BMO Capital
1M ago
FDMT
4D Molecular focuses pipeline to prioritize 4D-150 in wet AMD, DME
PremiumThe Fly
4D Molecular focuses pipeline to prioritize 4D-150 in wet AMD, DME
1M ago
FDMT
4D Molecular announces interim data on 4D-150 SPECTRA clincial trial
PremiumThe Fly
4D Molecular announces interim data on 4D-150 SPECTRA clincial trial
1M ago
FDMT
4D Molecular price target lowered to $46 from $79 at BofA
PremiumThe Fly
4D Molecular price target lowered to $46 from $79 at BofA
2M ago
FDMT
4D Molecular announces publication of 4D-150 preclinical data
PremiumThe Fly4D Molecular announces publication of 4D-150 preclinical data
2M ago
FDMT
4D Molecular initiated with an Underweight at Morgan Stanley
Premium
The Fly
4D Molecular initiated with an Underweight at Morgan Stanley
3M ago
FDMT
4D Molecular Therapeutics’ Positive Q3 and Strategic Advances
Premium
Company Announcements
4D Molecular Therapeutics’ Positive Q3 and Strategic Advances
3M ago
FDMT
4D Molecular reports Q3 EPS (79c), consensus (70c)
PremiumThe Fly
4D Molecular reports Q3 EPS (79c), consensus (70c)
3M ago
FDMT
4D Molecular downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe Fly
4D Molecular downgraded to Neutral from Overweight at Cantor Fitzgerald
5M ago
FDMT
RBC says 4D Molecular ‘oversold’ after ‘right decision’ about Phase 3 pivot
PremiumThe Fly
RBC says 4D Molecular ‘oversold’ after ‘right decision’ about Phase 3 pivot
5M ago
FDMT
4D Molecular falls after wet AMD data is viewed as mixed
PremiumThe Fly
4D Molecular falls after wet AMD data is viewed as mixed
5M ago
FDMT
4D Molecular price target raised to $39 from $38 at Chardan
PremiumThe Fly4D Molecular price target raised to $39 from $38 at Chardan
5M ago
FDMT
4D Molecular announces data from PRISM, 4FRONT trials
Premium
The Fly
4D Molecular announces data from PRISM, 4FRONT trials
5M ago
FDMT
JMP Securities healthcare analysts hold an analyst/industry conference call
Premium
The Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
5M ago
OPT
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >